National Review
The Race-Marxists Finally Went Too Far
What good American would disagree that “black lives matter”? Who could be opposed to “diversity, equity, and inclusion”? Who doesn’t believe…
Newsweek
The Shaky Case for Mandating Gender Diversity on Corporate Boards
It’s a good time to be a female business executive in America. The percentage of firms with female CEOs is rising, and a …
National Review
COP26 Cables: Nothing Is Quite as It Seems in Glasgow
My Competitive Enterprise Institute colleagues and I are filing brief cables on COP26, the international climate conference being held in Glasgow, Scotland. Below is our…
Forbes
Stopping Biden’s Build Back Better Act And The Bipartisan Infrastructure Plan Is Not Enough
Observing policymakers’ behavior, the only certainties regarding the next crisis to befall the Nation once the pandemic is in the rearview mirror are that Congress…
National Review
What’s Taking the FDA So Long on COVID Drug Molnupiravir?
On October 1, pharmaceutical companies Merck and Ridgeback Biotherapeutics announced that their investigational oral antiviral drug Molnupiravir reduced the risk of hospitalization or death…
Inside Sources
Minimum Wages Don’t Create Jobs
There are more than 10 million job openings in America right now. The worker shortage is contributing to goods shortages, rising prices and supply network…